Novo Nordisk Foundation is currently accepting applications for its Clinical Emerging Investigator 2027. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About Novo Nordisk Foundation - Clinical Emerging Investigator
The Clinical Emerging Investigator grant aims to enhance Danish clinical and translational research at an international level. It supports clinically active doctors in developing ambitious, clinically relevant research projects over five years, ensuring that the researchers maintain a strong clinical presence throughout the project duration.
Benefits of Novo Nordisk Foundation - Clinical Emerging Investigator
- Successful applicants can receive up to DKK 12,500,000 per grant. This funding is intended to facilitate the development of research projects that maintain a balance between research and clinical duties, ensuring the integration of research within the clinical environment.
Novo Nordisk Foundation - Clinical Emerging Investigator Requirements
- Applicants must be medical doctors (MDs) with a Ph.D. or a dr. med.
- Applicants must not hold the position of associate professor at the time of application.
- Projects with industrial or commercial purposes are ineligible.
- Projects focused solely on development without a research component are also ineligible.
- Applicants are required to allocate 20% to 60% of their time to research, with the remaining time dedicated to clinical work at a Danish hospital.
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
20 January, 2027
Opportunity Application
View details of
Novo Nordisk Foundation - Clinical Emerging Investigator
Apply for Novo Nordisk Foundation - Clinical Emerging Investigator